Alicia Moreno‐Gonzalez

Maxygen (United States)

Papers

1

Total Citations

5

H-Index

1

About

Dr. Alicia Moreno-Gonzalez is a pioneering oncologic researcher whose work centers on interventional oncology and the safety of novel ablation technologies for metastatic cancer. Her most significant contribution comes from the landmark study, "The Safety of Pulsed Electric Field Ablation Before Standard of Care Treatment for Patients With Metastatic Cancer" (2025), which has already garnered 5 citations in its early publication. This groundbreaking work evaluates the Aliya pulsed electric field (PEF) ablation system, demonstrating its safety when applied to lung lesions during diagnostic biopsy, prior to first-line standard of care therapy. By establishing that PEF ablation can be safely integrated into the biopsy procedure for patients with metastatic disease, Dr. Moreno-Gonzalez has opened new avenues for minimally invasive, combination treatment strategies. Her research addresses a critical gap in oncologic care—how to safely combine diagnostic and therapeutic interventions without delaying or compromising standard treatments. This work holds particular promise for improving outcomes in patients with metastatic lung cancer, where timely, multimodal approaches are essential. Dr. Moreno-Gonzalez’s focus on procedural safety and innovative energy-based therapies positions her as a rising leader in the field of interventional oncology, with her findings likely to influence future clinical protocols and inspire further investigation into PEF technology’s therapeutic potential.

Research Focus

Key Achievements

1
H-Index
1
Papers
5
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
The Safety of Pulsed Electric Field Ablation Before Standard of Care Treatment for Patients With Metastatic Cancer
5 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Maxygen (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago